Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), bought 30,000 shares at $5.16 ($155K) on 2022-11-07, disclosed to the SEC on 2022-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AUPH | SELL | 2021-11-03 | $1.4M | — | Filing → |
| AUPH | SELL | 2021-09-22 | $2.7M | — | Filing → |
| AUPH | SELL | 2021-09-16 | $958K | — | Filing → |